Malignant ascites: pathophysiology and treatment

E Cavazzoni, W Bugiantella, L Graziosi… - International Journal of …, 2013 - Springer
Malignant ascites (MA) accompanies a variety of abdominal and extra-abdominal tumors. It
is a primary cause of morbidity and raises several treatment challenges. MA has several …

Best practice for perioperative management of patients with cytoreductive surgery and HIPEC

C Raspé, L Flöther, R Schneider, M Bucher… - European Journal of …, 2017 - Elsevier
Due to the significantly improved outcome and quality of life of patients with different tumor
entities after cytoreductive surgery (CRS) and HIPEC, there is an increasing number of …

Cell–cell and cell–matrix dynamics in intraperitoneal cancer metastasis

KL Sodek, KJ Murphy, TJ Brown… - Cancer and Metastasis …, 2012 - Springer
The peritoneal metastatic route of cancer dissemination is shared by cancers of the ovary
and gastrointestinal tract. Once initiated, peritoneal metastasis typically proceeds rapidly in a …

Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case–control study on survival in patients with two year follow-up

A Fagotti, B Costantini, M Petrillo, G Vizzielli… - Gynecologic …, 2012 - Elsevier
OBJECTIVES: To compare survival data in platinum-sensitive recurrent ovarian cancer
patients submitted to secondary cytoreduction (SCR) plus hyperthermic intraperitoneal …

Diagnosis and management of peritoneal metastases from ovarian cancer

E Halkia, J Spiliotis… - … research and practice, 2012 - Wiley Online Library
The management and the outcome of peritoneal metastases or recurrence from epithelial
ovarian cancer are presented. The biology and the diagnostic tools of EOC peritoneal …

The potential role of the proteases cathepsin D and cathepsin L in the progression and metastasis of epithelial ovarian cancer

MZI Pranjol, N Gutowski, M Hannemann, J Whatmore - Biomolecules, 2015 - mdpi.com
Epithelial ovarian cancer (EOC) is the leading cause of death from gynecologic
malignancies and has a poor prognosis due to relatively unspecific early symptoms, and …

Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in …

PA Cascales-Campos, J Gil, E Gil… - Annals of surgical …, 2014 - Springer
Background We analyze the efficacy of hyperthermic intraoperative intraperitoneal
chemotherapy (HIPEC) for microscopic residual disease in patients with stage IIIC/IV ovarian …

Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC)

M Desantis, JL Bernard, V Casanova… - … archives of surgery, 2015 - Springer
Purpose Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) are a novel curative treatment option for selected patients with peritoneal …

Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi‐institutional study

M Deraco, S Virzì, DR Iusco, F Puccio… - … Journal of Obstetrics …, 2012 - Wiley Online Library
Please cite this paper as: Deraco M, Virzì S, Raspagliesi F, Iusco D, Puccio F, Macrì A,
Famulari C, Solazzo M, Bonomi S, Grassi A, Baratti D, Kusamura S. Secondary cytoreductive …

[HTML][HTML] Overexpression of cysteine cathepsin L is a marker of invasion and metastasis in ovarian cancer

W Zhang, S Wang, Q Wang, Z Yang… - Oncology …, 2014 - spandidos-publications.com
Cysteine cathepsins (CTSs) are involved in the degradation and remodeling of the
extracellular matrix and are associated with cellular transformation, differentiation, motility …